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Research
AbstrACt
Objective To examine factors associated with HIV 
infection among transgender women in Cambodia.
Design Cross-sectional study.
settings HIV high-burden sites including the capital city 
and 12 provinces.
Participants This study included 1375 sexually active 
transgender women with a mean age of 25.9 years (SD 
7.1), recruited by using respondent-driven sampling for 
structured questionnaire interviews and rapid finger-prick 
HIV testing.
Primary outcome measure HIV infection detected by 
using Determine antibody test.
results HIV prevalence among this population was 5.9%. 
After adjustment for other covariates, participants living in 
urban areas were twice as likely to be HIV infected as those 
living in rural areas. Participants with primary education 
were 1.7 times as likely to be infected compared with those 
with high school education. HIV infection increased with age; 
compared with those aged 18–24 years, the odds of being 
HIV infected were twice as high among transgender women 
aged 25–34 years and 2.8 times higher among those aged 
≥35 years. Self-injection of gender affirming hormones 
was associated with a fourfold increase in the odds of HIV 
infection. A history of genital sores over the previous 12 
months increased the odds of HIV infection by threefold. 
Transgender women with stronger feminine identity, dressing 
as a woman all the time, were twice as likely to be HIV 
infected compared with those who did not dress as a woman 
all the time. Having never used online services developed 
for transgender women in the past six months was also 
associated with higher odds of being HIV infected.
Conclusions Transgender women in Cambodia are at 
high risk of HIV. To achieve the goal of eliminating HIV in 
Cambodia, effective combination prevention strategies 
addressing the above risk factors among transgender 
women should be strengthened.
IntrODuCtIOn
Globally, transgender women are at high risk 
for HIV infection, and little is known about 
the burden of HIV infection and its related 
factors in this population. A 2013 systematic 
review showed that the global HIV preva-
lence among transgender women was 19%, 
with low-income and middle-income coun-
tries having a slightly lower prevalence of 
18% compared with 22% in high-income 
countries.1 The probability of being infected 
with HIV among transgender women was 
approximately 49 times higher than among 
the general adult population.1 Epidemiolog-
ically, transgender women share some HIV 
risk factors with other populations, such as 
ulcerative sexually transmitted infections 
(STIs),2 3 multiple substance use, victimisa-
tion, intimate partner violence,4 unprotected 
sex,5 multiple sex partners6 and injecting 
drug use.5–7
However, transgender women encounter 
additional and unique biological, social, 
strengths and limitations of this study
 ► This is a rare and the second ever Integrated 
Biological and Behavioral Survey among 
transgender women—one of the most vulnerable 
and understudied populations in Cambodia and 
globally.
 ► This study covered HIV high-burden sites including 
the capital city and 12 provinces, thus providing 
more nationally generalisable results.
 ► This study identified important risk factors for HIV 
infection among transgender women, which require 
being addressed in order to reduce HIV infection 
among this key population.
 ► Limitations of the study included potential bias 
of self-reported measures, participant sampling, 
the cross-sectional nature of the data that limits 
causation inferences and the backward selection of 
variables in multivariable analysis.
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cultural, legal and economic issues, which increase their 
vulnerability to HIV. Transgender women are margin-
alised legally and economically through discriminative 
legislation and practice, which accelerates their vulner-
ability to HIV infection by confining their job options 
to sex work. Sex work in turn exacerbates their stigma-
tisation and alienation,8 and further increases their HIV 
risk.9 10Stigmatisation and discrimination further increase 
the risk of HIV infection by preventing transgender 
women from seeking essential health information and 
services.11 Depression and low self-esteem, which are 
common psychological consequences of stigma, further 
weaken the bargaining power for condom use in sexual 
relationships, resulting in heightened vulnerability to 
HIV infection.5 12–15 Transgender women who have sex 
with men often engage in receptive anal intercourse, 
which increases their risk of HIV acquisition, compared 
with insertive sexual partners.2 Syndemics of illicit drug 
use, abuse by family members and mental health often 
occur together16 and are often associated with less likeli-
hood of transgender women to use condoms during sex 
with commercial partners.17 In addition, the confluence 
of arbitrary arrests,18 19 violence,16 20 economic pressures21 
and other social problems further aggravates mental 
health risks among transgender women, causing them to 
engage in risky sexual behaviours.6 17
In Southeast Asia, a systematic review of studies from 
Indonesia, Thailand and Vietnam demonstrated that 
transgender women are particularly at high HIV risk, 
with an estimated HIV prevalence of 26.1%, 12.2% and 
6.7%, respectively.1 In Cambodia, up to 2012, trans-
gender women were traditionally included in HIV 
prevention programmes targeting men who have sex with 
men (MSM). As a result, their unique needs were not 
reflected in HIV programmes’ goals.22 There was also a 
lack of transgender women-specific data to quantify the 
number reached by outreach programmes and services. 
In 2012, the first Integrated Biological and Behavioral 
Survey (IBBS) that specifically included transgender 
women in Cambodia found an HIV prevalence of 4.2% 
among this population,22 which was six times higher than 
the 0.7% prevalence among the general adult popu-
lation aged 15–45 years,23 and about twice higher than 
the 2.1% among MSM.24 This 2012 study also found that 
older age (>35 years), residing in Siem Reap province (a 
major tourist site), having sex during or after drug use, 
not using a condom during the last anal sex and low 
self-esteem were associated with HIV infection among 
transgender women.22
Recognising the differences in HIV vulnerability and 
prevention needs between transgender women and MSM, 
in 2013 the National Center for HIV/AIDS, Dermatology 
and STD (NCHADS) separated these two populations 
in its revised Standard Operating Procedure known as 
Boosted Continuum of Prevention, Care and Treatment 
(B-CoPCT).25 Transgender women have since been 
considered a distinct at-risk group for HIV surveillance 
and programming. The National B-CoPCT approach 
aims to increase the uptake of HIV testing and coun-
selling and other related services, ensure the quality of 
outreach and strengthen service delivery to meet specific 
needs of key populations, including transgender women, 
in-order to achieve Cambodia’s 3.0 goal (ie, zero new 
HIV infection, zero discrimination and zero AIDS-related 
deaths) by 2020.
This study was conducted to explore the HIV prev-
alence and identify risk factors associated with HIV 
infection among transgender women in Cambodia. The 
study findings will help determine ways in which services 
and policies can be tailored for this key population.
MethODs
Study design and sites
Between December 2015 and February 2016, a cross-sec-
tional study was conducted in the capital city of Phnom 
Penh and 12 provinces, namely Battambang, Banteay 
Meanchey, Kampong Cham, Kandal, Koh Kong, Kampong 
Chhnang, Kampong Speu, Prey Veng, Preah Sihanouk, 
Siem Reap, Svay Rieng and Tbong Khmum. These sites 
were purposively selected from the 23 HIV high-burden 
operational districts identified by NCHADS.26 27 The 
study was a combination of a biological (blood test) 
and behavioural (face-to-face interview) survey using 
Respondent-Driven Sampling method to reach the target 
population.
sample size and sampling procedures
The sample size calculation was based on an assumption 
that HIV prevalence would have changed between the 
first and the current IBBS. The minimum sample size 
required for this study was 1380, which would result in 
sufficient power to detect a priori significant difference 
in HIV prevalence, as expressed in the following null and 
alternative hypotheses. The hypothesis test was that of 
one-sample proportion compared with the null hypoth-
esis.
The null hypothesis (H0): HIV prevalence among trans-
gender women remains constant at 4.2%, similar to that 
found in the 2012 IBBS.
The alternative hypothesis (Ha): HIV prevalence among 
transgender women has decreased by 1.2% from 4.2% in 
2012 to 3.0% in the present IBBS.










 ► P0 = estimated proportion in H0. (In the most recent 
survey, HIV prevalence among transgender women 
was 4.2% in 2012).
 ► P1 = estimated proportion in Ha. (The expected HIV 
prevalence among transgender women in the current 
study is about 3.0%).
 ► Z(1-α)⁄) = significance level at 5% in response to one-sid-
ed test (Z score=1.645).
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 ► Z(1- β) = power level of 80% (Z score=0.83).
 ► Refusal rate of 10%.
 ► Design effect is assumed to be one.
This sample size was stratified by study site. Roughly 
half of the estimated transgender women in each study 
site were recruited. However, in five provinces where the 
estimated number of transgender women was <100, all 
transgender women were recruited. Potential participants 
were included in the study if they (1) were biologically 
male at birth and self-identified as a woman or third 
gender, (2) were Khmer-speaking, (3) were at least 18 
years of age at the time of screening, (4) reported having 
had sex with at least one man within the past 12 months 
and (5) were able and willing to provide an informed 
consent.
Among the 13 study sites, data collection was conducted 
in 20 locations (6 locations in Phnom Penh and 14 loca-
tions in the remaining provinces). The number of the 
selected locations was determined based on the required 
sample size in each study site. Our participants, including 
the seeds and the people the seeds referred, had to meet 
the eligibility criteria. These participants were recruited 
from the entire transgender population in the study sites. 
However, the initial seeds at each site were recruited 
through our implementing partners. First, four ‘seeds’ 
(two seeds aged 18–24 and two seeds 25 or older) who 
were well connected with other transgender women in 
each location were selected by outreach workers from 
implementing partners (local non-governmental organ-
isations (NGOs)) based in the selected locations. These 
seeds had to meet the above-mentioned eligibility criteria 
for participation and have an established and large social 
network consisting of ≥10 other transgender women in 
their given location. Eligibility to participate as a seed 
was determined by the leader of the data collection team, 
using a paper-based eligibility form.
Second, each seed was given a personal identity 
number and enrolled in the study. Third, each seed was 
given three coupons and asked to refer three additional 
transgender women. US$2 was given to each seed for a 
successful referral. Each seed was expected to extend to 
3–6 ‘recruitment waves’ in each location. If the initial 
seeds did not recruit participants, or if enrolment was 
halted because all recruitment chains had ‘dried up’ (ie, 
stopped recruiting), additional seeds were selected. In 
total, 80 seeds were selected by the outreach workers, and 
a total of 1375 transgender women were enrolled in the 
study. Referred participants were initially screened by the 
data collectors for eligibility.
Data collection training
Data were collected by three teams; each team comprised 
one field supervisor, five interviewers, one lab technician 
and one counsellor. Lab technicians and counsellors were 
from the Municipal or Provincial AIDS and STI Program 
of the study sites. Data collection teams were trained 
for 3 days on study protocol, research ethics, interview 
techniques and data collection procedures provided by 
the principal investigators and research coordinators.
Data collection procedures
Biological data collection
To determine HIV prevalence, all participants received 
onsite rapid finger-prick testing. Pre-test counselling was 
provided by qualified, well-trained counsellors working 
for voluntary confidential counselling and testing 
(VCCT) centres. Participants could receive their HIV 
test result verbally after the questionnaire interview. A 
blood sample was obtained from each participant by a 
trained laboratory technician through finger-prick and 
tested for HIV using Determine test, in keeping with the 
national protocol.28 Post-test counselling was provided for 
each participant regardless of their HIV test result by the 
same counsellor who conducted the pre-test counselling 
in accordance with NCHADS HIV testing guidelines.28 
Participants who were HIV reactive and did not know their 
HIV status were referred by the counsellor for confirma-
tory testing at the nearest VCCT centre. The quality of 
HIV tests was monitored using quality control samples. 
Discordant results between the screening and confirma-
tory tests were investigated to elucidate potential causes 
and minimise potential erroneous results. In the case of 
human error, individuals performing screening tests were 
retrained before resuming their involvement in the study.
After HIV testing, the participant was interviewed by a 
well-trained interviewer using a computer-assisted survey 
instrument. The questionnaire was set up in Qualtrics, a 
web-based application, and run on an Android tablet. HIV 
testing and interviews were conducted in the selected 20 
locations including drop-in centres, private houses and 
offices of implementing partners, depending on partici-
pants’ convenience.
Questionnaire development and measures
The questionnaire was developed using standardised 
and validated tools adapted from TGIBBS-2012,22 FHI 
360’s guideline for Behavioral Surveillance Survey29 and 
NCHADS’s Boosted-CoPCT25 to measure key variables 
related to the objectives of the study. The questionnaire 
was initially drafted in English and translated into Khmer, 
the national language of Cambodia. Consultative meet-
ings to improve the draft questionnaire were held with 
representatives of transgender women, communities 
and NGOs working with transgender women, as well as 
researchers and practitioners working on HIV and AIDS 
in Cambodia. The questionnaire was pre-tested with 20 
transgender women in Phnom Penh and finalised based 
on findings.
The questionnaire collected information on socioeco-
nomic characteristics, transgender identity and related 
experiences, sexual behaviours and condom use with 
different types of sexual partners, HIV/STI screening and 
care seeking behaviours, substance use and exposure to 
HIV programmes. For details of the questionnaire, please 
see online supplementary file 1.
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Data analyses
HIV prevalence was calculated by dividing the total 
number of participants with HIV reactive test results 
with the total number of participants. To examine the 
associated factors of HIV infection, we conducted both 
bivariate and multivariable analyses. In the bivariate anal-
yses, we compared all characteristics and behavioural 
variables of participants with a reactive test result to those 
of participants with a non-reactive test result. Among 
participants who tested HIV positive, additional analyses 
were conducted to assess whether there was a significant 
difference in sexual behaviours of those who were aware 
of their HIV-positive status and of those who were not. χ2 
test or Fisher’s exact test (for an expected cell value of ≤5) 
was used for categorical variables, while Student’s t-test 
was used for continuous variables. To facilitate the model, 
some continuous variables, such as age, were transformed 
to categorical variables. A multivariable logistic regres-
sion model was constructed to examine independent 
factors associated with HIV infection. Variables with a 
significance level of p<0.05 in the bivariate analyses were 
simultaneously included in the model. Backward elimina-
tion method was then used to eliminate variables with the 
highest p-value one-by-one from the model. STATA V.12.0 
for Windows was used to conduct the data analyses.
ethICAl stAteMent
Participation in this study was voluntary, and a written 
informed consent was obtained from each study partic-
ipant after a detailed description of the study objective 
and procedures was explained to them. Participants were 
informed that they could stop responding to questions 
and discontinue their participation at any time. Interviews 
were conducted at a private place, and confidentiality was 
enhanced by assigning a unique and anonymous code to 
each participant. No personal identifiers were contained 
in the questionnaires or dataset. 
results
HIV prevalence
Of 1375 participants tested, 81 (5.9%) had an HIV reac-
tive test; of whom, 42 (52%) were not aware of their HIV 
status prior to the study. Out of the 39 cases who already 
knew their status, 37 (94.9%) were currently on HIV 
treatment, with the other two reporting having dropped 
out of the treatment.
socio-demographic characteristics
As shown in table 1, the majority of the participants 
(83.4%) were recruited from urban communities; 53.0% 
were younger than 25 years and 97.2% had never been 
married. More than two-thirds of participants (68.6%) 
had completed high school and 9.1% had a higher educa-
tion. The most common main occupations reported by 
the participants were hair dressers/beauticians (35.1%), 
labourers/farmers (17.5%) and entertainment workers 
(14.8%). More than one-third of participants (38.6%) 
reported an average monthly income in the past 
six months of US$100–199, while 16.5% reported it to be 
>US$300. Regarding gender identity, 42.2% identified 
themselves as female, while 57.2% identified themselves 
as third gender. Almost half (48.0%) of the participants 
reported dressing as a woman all the time; 45% ever 
used hormone/non-hormone substance; and 14.0% ever 
injected hormones.
HIV prevalence was significantly higher among partic-
ipants living in urban communities compared with 
participants living in rural communities (6.5% vs 2.6%, 
p=0.02). The HIV prevalence was also significantly 
different by age group: 3.0% of participants in the age 
group of 18–24 years, 8.2% in 25–34 years, 13.1% in 
35–44 years and 11.4% in 45 years or older (p<0.001). 
HIV prevalence was also significantly higher among those 
who never attended school or dropped out of primary 
school compared with those who at least attended high 
school or higher (10.4% vs 8.0%, p<0.001). In addition, 
HIV prevalence was significantly higher among trans-
gender women who were NGO staff (mainly HIV-focused 
NGOs) (20.6%) and those who were unemployed (9.4%) 
(p=0.03). HIV prevalence was significantly higher among 
transgender women who reported dressing as women 
all the time (8.5% vs 3.5%, p=0.001), among those who 
ever used female hormones (8.1% vs 4.1%, p=0.02) and 
among those who ever injected hormones (9.1% vs 5.2%, 
p=0.002). Moreover, HIV prevalence was significantly 
higher among transgender women who reported never 
using online services developed specifically for MSM or 
transgender women, such as Facebook group pages or 
various websites (9.5% vs 3.9%, p<0.001).
sexual behaviours
Sexual behaviours among transgender women with reac-
tive and non-reactive HIV test are shown in table 2. An 
overwhelming majority of study participants (87.5%) 
reported only having had receptive anal sex in the past 12 
months. Of the total, 86.0% reported having had anal sex 
with at least one man within the previous three months, 
with the median number of male sex partners in the past 
three months being three (IQR 1–9). Of those who were 
sexually active with men in the past three months, 61.9% 
reported having used a condom at last sex with a man.
A total of 94.8% of participants who had anal sex in the 
prior three months reported having at least one non-trans-
actional male sex partner within the past three months; of 
which, 62.1% reported always using condoms with their 
non-transactional male sex partners. Of participants who 
had sex in the past three months, 41.8% reported having 
sex with at least one man in exchange for money or gift; 
of whom 60.0% reported always using condoms with the 
partners.
Table 2 also shows that HIV prevalence was significantly 
higher among participants who reported having had anal 
sex with a man in the past three months (6.5% vs 2.1%, 
p=0.02) and among those who reported having had sex 
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Table 1 Comparison of socio-demographic, gender identity and hormone use characteristics of transgender women with and 
without a reactive HIV test
Socio-demographics, gender 
identity and hormone use 
Total (n=1375)
HIV test result
Reactive (n=81) Non-reactive (n=1294)
n (%) n (%) n (%) p Value*
Community type
  Urban 1146 (83.4) 75 (6.5) 1071 (93.5) 0.02
  Rural 229 (16.6) 6 (2.6) 223 (97.4)
Age (years)
  18–24 729 (53.0) 22 (3.0) 707 (97.0) <0.001
  25–34 503 (36.6) 41 (8.2) 462 (91.8)
  ≥35 143 (10.4) 18 (12.6) 125 (87.4)
Current marital status
  Married 7 (0.5) 0 (0.0) 7 (100) 0.47
  Widowed/divorced/separated 18 (1.3) 1 (5.6) 17 (94.4)
  Never married 1334 (97.2) 78 (5.9) 1256 (94.1)
  Refused to answer 16 (1.2) 2 (15.4) 11 (84.6)
Years of formal education completed
  Primary (0–6 years) 307 (22.3) 32 (10.4) 275 (89.6) <0.001
  High school or higher (>7 years) 1068 (77.7) 49 (4.6) 1019 (95.4)
Main occupation
  Unemployed 64 (4.7) 6 (9.4) 58 (90.6) 0.03
  Hair dresser/beautician 482 (35.1) 24 (5.0) 458 (95.0)
  Office worker 50 (3.6) 3 (6.0) 47 (94.0)
  Labour/farmer 241 (17.5) 15 (6.2) 226 (93.8)
  Seller 149 (10.8) 10 (6.7) 139 (93.3)
  Entertainment worker 203 (14.8) 10 (4.9) 193 (95.1)
  Student 108 (7.9) 1 (0.9) 107 (99.1)
  Non-governmental organisation 
staff
34 (2.5) 7 (20.6) 27 (79.4)
  Other 44 (3.2) 5 (11.4) 39 (88.6)
Monthly income in the past six months (US$)
  <100 351 (25.6) 22 (6.3) 329 (93.7) 0.70
  100–199 530 (38.6) 29 (5.5) 501 (94.5)
  200–299 266 (19.3) 19 (7.1) 247 (92.9)
  ≥300 226 (16.5) 11 (4.9) 215 (95.1)
Gender identity (self-identified)
  Female 580 (42.2) 29 (5.0) 551 (95.0) 0.35
  Third gender 786 (57.2) 52 (6.6) 734 (93.4)
  Uncertain 8 (0.6) 0 (0.0) 8 (100)
Frequency of dressing as a woman
  All the time 660 (48.0) 56 (8.5) 604 (91.5) 0.001
  Not all the time 715 (52.0) 25 (3.5) 689 (96.5)
Ever injected hormones
  No 1123 (81.7) 58 (5.2) 1065 (94.8) 0.02
  Yes 252 (18.3) 23 (9.1) 229 (90.9)
Ever self-injected hormones
Continued
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with at least one man in exchange for money or gift in the 
prior three months (8.1% vs 5.4%, p=0.04) compared with 
participants who did not report these sexual behaviours.
sexual behaviours and awareness of hIV status
Among the participants who had HIV reactive tests, 
additional analyses were conducted to see if there were 
differences in sexual behaviours among those who 
self-reported a positive status and those who did not. 
Participants who did not report or were unaware of their 
positive status were significantly less likely to report using 
a condom at last sexual intercourse (52.4% vs 79.0%, 
p=0.01). No other significant differences were found.
sexually transmitted infections
Overall, 14.0% of participants reported having had at least 
one STI symptom in the past 12 months. Anal and peri-
anal symptoms were most commonly reported (6.1%). 
As shown in table 3, HIV prevalence was significantly 
higher among participants who reported having had an 
STI symptom compared with that among participants 
who did not have an STI symptom in the past 12 months 
(11.4% vs 5.0%, p<0.001). HIV prevalence was also signifi-
cantly higher among participants who reported having 
had an ulceration or sore in the genital area in the past 
12 months compared with that among participants who 
did not have it (15.2% vs 5.6%, p<0.001).
substance use
As shown in table 5, the majority (75.9%) of participants 
reported drinking at least one can of beer or a glass of 
wine in the past three months, while 10.1% reported using 
amphetamine-type stimulants (Yama, Crystal Ice, Ecstasy) 
and 0.9% reported using other drugs (marijuana, heroin) 
in the previous 12 months. Of total, 1.5% reported having 
injected any illicit drugs in the past three months.
Table 4 also shows that HIV prevalence was signifi-
cantly higher among participants who did not drink 
alcohol when compared with that among participants 
who reported drinking at least one can of beer or a glass 
of wine in the past three months (8.5% vs 5.1%, p=0.02). 
Moreover, HIV prevalence was significantly higher among 
participants who reported injecting any illicit drugs in the 
past three months compared with participants who did 
not (15.0% vs 5.8%, p=0.01).
Factors associated with hIV infection
Table 5 presents independent factors associated with HIV 
infection in multivariable logistic regression analyses. 
After adjustment for other covariates, participants living 
in urban areas were twice as likely to be HIV infected as 
those living in rural areas (adjusted OR (AOR) 2.7, 95% 
CI 1.1 to 6.5). Participants with primary education were 
1.7 times as likely to be infected compared with those with 
high school education (AOR 1.7, 95% CI 1.0 to 2.9). HIV 
infection increased with age; compared with those aged 
18–24 years, the odds of being HIV infected were twice as 
high among transgender women aged 25–34 years (AOR 
2.1, 95% CI 1.2 to 3.6) and 2.8 times higher among those 
aged ≥35 years (AOR 2.8, 95% CI 1.3 to 6.1). Self-injec-
tion of gender affirming hormones was associated with a 
fourfold increase in the odds of HIV infection (AOR 4.4, 
95% CI 1.1 to 17.3). A history of genital sores over the 
previous 12 months increased the odds of HIV infection 
by threefold (AOR 3.0, 95% CI 1.2 to 7.8). Transgender 
women with stronger feminine identity, dressing as a 
woman all the time, were twice as likely to be HIV infected 
compared with those who did not dress as a woman all 
the time (AOR 2.1, 95% CI 1.2 to 3.8). Having never used 
online services developed for transgender women in the 
past six months was also associated with higher odds of 
being HIV infected (AOR 1.9, 95% CI 1.2 to 3.2).
DIsCussIOn
This study reveals an HIV prevalence of 5.9% among 
transgender women in Cambodia. This prevalence was 
about 20 times higher than the 0.3% among women 
attending antenatal care clinics in 2014 who represent the 
general adult population aged 15–45 years,30 and about 
2.5 times higher than the 2.3% among MSM in 2014.26 
Socio-demographics, gender 
identity and hormone use 
Total (n=1375)
HIV test result
Reactive (n=81) Non-reactive (n=1294)
n (%) n (%) n (%) p Value*
  No 1358 (98.8) 77 (5.7) 1281 (94.3) 0.002
  Yes 17 (1.2) 4 (25.5) 13 (76.5)
Ever shared needles when injecting hormones/beauty substances
  No 1355 (98.5) 78 (5.8) 550 (94.2) 0.33
  Yes 20 (3.2) 2 (10.0) 18 (90.0)
Ever used online services developed for men who have sex with men/transgender (eg, Facebook, website)
  No 483 (35.1) 46 (9.5) 437 (90.5) <0.001
  Yes 892 (64.9) 35 (3.9) 857 (96.1)
*Χ2 or Fisher’s exact test was used as appropriate.
Table 1 Continued 
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This observed prevalence emphasises that transgender 
women in Cambodia are at high risk of HIV and is consis-
tent with global literature regarding the high burden of 
HIV among this transgender population.1
Although statistically non-significant (p=0.13), the 
prevalence found in this study was higher than the prev-
alence of 4.2% reported in the smaller (n=891) TGIBBS 
conducted in 201222 and was therefore contrary to our 
hypothesised expectations of reduction in HIV prevalence 
among this population. Recent progress in Cambodia, 
where 73% of all estimated HIV-positive people or 93% 
of those who have been aware of their positive status 
are in care,31 had prompted us to hypothesise the lower 
prevalence. Although we have no concrete evidence 
regarding the non-significant increase of HIV prevalence, 
we suggest that it may be related to the sampling variation 
in the two surveys. The previous study recruited partici-
pants only from the capital city and five provinces (Phnom 
Penh, Battambang, Banteay Meanchey, Kampong Cham, 
Siem Reap and Preah Sihanouk),22 whereas our study 
expanded to additional eight provinces.
More than half (52%) of those who had HIV reactive tests 
reported that they had never learnt about their HIV-posi-
tive status before they participated in the study. We believe 
that this self-reporting of the HIV status is realistic. Since 
we were concerned that those who were already aware of 




Reactive (n=81) Non-reactive (n=1294)
n (%) n (%) n (%) p Value*
Role in anal sex with a man (past 12 months)
  Insertive 29 (2.2) 1 (3.5) 28 (96.5) 0.73
  Receptive 1145 (87.5) 72 (6.3) 1073 (93.7)
  Both 135 (10.3) 7 (5.2) 128 (94.8)
Had anal sex with a man (past three months)
  No 192 (14.0) 4 (2.1) 188 (97.9) 0.02
  Yes 1183 (86.0) 77 (6.5) 1106 (93.5)
Number of male sexual partners (past three months)
  <2 512 (37.3) 24 (4.7) 488 (95.3) 0.14
  ≥2 861 (62.7) 57 (6.6) 804 (93.4)
Used a condom at last sex (past three months)
  No 451 (38.1) 27 (6.0) 423 (94.0) 0.57
  Yes 732 (61.9) 50 (6.8) 682 (93.2)
Had anal sex with a man, not in exchange for money or gift (past three months)
  No 61 (5.2) 5 (8.2) 56 (91.8) 0.37
  Yes 1122 (94.8) 72 (6.4) 1050 (93.6)
Number of male sexual partners, not in exchange for money or gift (past three months)
  <2 357 (31.9) 24 (6.7) 333 (93.3) 0.78
  ≥2 763 (68.1) 48 (6.3) 715 (93.7)
Condom use with male sexual partner not in exchange for money or gift (past three months)
  Not always 697 (62.1) 50 (7.2) 647 (92.8) 0.19
  Always 425 (37.9) 22 (5.2) 403 (94.8)
Had anal sex with a man in exchange for money or gift (past three months)
  No 688 (58.2) 37 (5.4) 651 (94.6) 0.04
  Yes 495 (41.8) 40 (8.1) 455 (91.9)
Number of male sexual partners in exchange for money or gift (past three months)
  <2 161 (32.5) 12 (7.5) 149 (92.6) 0.72
  ≥2 334 (67.5) 28 (8.4) 306 (91.6)
Condom use with male sexual partner in exchange for money or gift (past three months)
  Not always 164 (40.0) 12 (7.3) 152 (92.7) 0.56
  Always 246 (60.0) 22 (8.9) 224 (91.1)
*χ2 test or Fisher’s exact test was used as appropriate.
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their HIV status may be unwilling to report their status, 
we decided to use well-trained counsellors who all were 
from the government’s VCCT centres. These counsellors 
had many years of experience in providing VCCT services 
and were better equipped to cope with difficult situations. 
In Cambodia, we believe people are more likely to trust 
their counsellors, as opposed to interviewers. However, as 
in all self-reported measures, the potential for response 
bias cannot be entirely ruled out.
This study also reports important findings related to 
factors associated with HIV infection among transgender 
women in Cambodia. First, the HIV prevalence among 
transgender women residing in urban communities was 
twice as high compared with that among transgender 
women living in rural communities. This finding is similar 
to that in a previous study that found a higher HIV preva-
lence in transgender women living in urban areas of Siem 
Reap and Phnom Penh compared with that among trans-
gender women living in other provinces.22 Findings from 
our study suggest that these differences may not neces-
sarily be attributable to common sexual risk practices. 
The mean number of sexual partners (8.4 vs 7.9, p=0.70) 
and the mean number of male commercial sexual part-
ners (0.7 vs 0.7, p=0.48) in the past three months among 
transgender women living in urban and rural communi-
ties were not significantly different. In addition, the rates 
of inconsistent condom use with male non-commercial 
sexual partners in the past three months were also similar 
in the two groups (58.0% vs 62%, p=0.32).
Given the failure of sexual risk behaviours to suffi-
ciently account for the difference in HIV prevalence, 
these data suggest that a higher HIV prevalence among 
sexual partners of transgender women in urban commu-
nities may possibly explain the higher probability of 
urban transgender women to get infected, although 
this may not be stated with certainty. This is particu-
larly relevant given that previous studies among all 
transgender women found a higher prevalence of HIV 
in urban areas.22 Studies among MSM in Cambodia 
have also found a higher prevalence of HIV in urban 
areas.24 32 In addition, a recent national sentinel survey 
among women attending antenatal care clinics found 
that HIV prevalence among women in urban areas was 
consistently high,30 implying that HIV prevalence in 
urban areas among most populations, who potentially 
include transgender women and their partners, is high. 
It is also possible that transgender population in urban 
communities face unique or additional risks compared 
with other members of this population in rural areas,22 
which could also contribute to the difference in HIV 
prevalence between urban and rural communities. Still, 
it is possible that those who knew they were positive may 
have moved to urban centres for care and treatment, 
which unfortunately cannot be examined further in this 





Reactive (n=81) Non-reactive (n=1294)
n (%) n (%) n (%) p Value*
Had experienced any STI symptom (past 12 months)
  No 1182 (86.0) 59 (5.0) 1123 (95.0) <0.001
  Yes 193 (14.0) 22 (11.4) 171 (88.6)
Ulceration or sores around the genitals (past 12 months)
  No 1329 (96.7) 74 (5.6) 1255 (94.4) <0.001
  Yes 46 (3.4) 7 (15.2) 39 (84.8)
Swelling around the genitals (past 12 months)
  No 1359 (98.8) 80 (5.9) 1279 (94.1) 1.000
  Yes 16 (1.2) 1 (6.3) 15 (93.7)
Abnormal urethral discharge (past 12 months)
  No 1339 (97.4) 77 (5.8) 1262 (94.2) 0.16
  Yes 36 (2.6) 4 (11.1) 32 (88.9)
STI symptoms around the anus (past 12 months)
  No 1291 (93.9) 73 (5.6) 1218 (94.4) 0.15
  Yes 84 (6.1) 8 (9.52) 76 (90.48)
STI symptoms in the mouth or throat (past 12 months)
  No 1336 (97.2) 76 (5.7) 1260 (94.3) 0.07
  Yes 39 (2.8) 5 (12.82) 34 (87.18)
*χ2 or Fisher’s exact test was used as appropriate.
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cross-sectional study. Further research is needed with 
regard to this observation.
Second, HIV prevalence among older transgender 
women (≥25 years) was significantly higher compared 
with that among their younger counterparts. This finding 
is similar to those of previous studies in Cambodia22 and 
Thailand.3 A possible explanation is that older trans-
gender women had been exposed to risks for a longer 
period of time; the number of their sexual partners 
accumulated over time and thus increased cumulative 
probability of HIV acquisition.22
Third, our study suggests that more overt feminine 
expression (eg, those who dressed as a woman all the 
time) was associated with a higher HIV prevalence. A 
study in the USA found that transgender women who 
disclosed their female gender identity possessed a higher 
HIV prevalence.33 In our study, these transgender women 
who dressed as a woman all the time had higher numbers 
of both male non-commercial (mean=8.1 vs 5.1, p=0.004) 
and male commercial sexual partners (mean=3.7 vs 1.6, 
p<0.001), compared with those who did not. Making their 
female status visible could render more chances to meet 
with men. However, it could make them difficult to find a 
decent job due to stigmatisation and discrimination, thus 
leading them to engage in sex work. This finding is in line 
with existing literature showing that transgender women 
try to have sex with men—both casual and paid sex—to 
prove or validate their female gender identity.34–36 In these 
contexts, ‘sex work provides both desired gender affirma-
tion and economic stability, often with greater financial 
rewards for sex without a condom’.34 The desire to affirm 
their gender identity and attractiveness to men also 
incentivises them to engage in casual sex with multiple 
partners.15 This sexual behaviour may make them more 
prone to HIV infection.
There is a tendency to self-inject gender-affirming 
hormones, often with shared needles, among transgender 
women in Cambodia.37 This risky practice was associated 
with an increased risk of HIV infection, implying that 
self-injecting was performed through unsafe means, and 
that injecting by a trained health or other professional 
might mitigate the likelihood of HIV infection. Although 
hormone injection to augment femininity is becoming 
more common, it can potentially cause adverse health 
effects among transgender women.3 38 A Thai study also 
found that transgender women who injected hormone to 
make them more feminine had a higher HIV prevalence.3
Fourth, transgender women who completed or 
dropped out of primary school had a higher HIV preva-
lence than those with high school education. This finding 
confirms results of the TGIBBS 2012 in Cambodia22 and 
other studies6 39 that associated low education with high 
HIV prevalence among transgender women. This has 
important implications for HIV programmes to ensure 




Reactive (n=81) Non-reactive (n=1294)
n (%) n (%) n (%) p Value*
Drank at least one can of beer or glass of wine in the past three months
  No 331 (24.1) 28 (8.5) 303 (91.5) 0.02
  Yes 1042 (75.9) 53 (5.1) 989 (94.9)
Frequency of having more than five drinks in 1 day in the past three months
  Never more than five drinks 336 (24.4) 28 (8.3) 308 (91.7) 0.17
  Less than once a month 771 (56.1) 40 (5.2) 731 (94.8)
  1–3 times a week 157 (11.4) 9 (5.7) 148 (94.3)
  Four or more times a week 111 (8.1) 4 (3.6) 107 (96.4)
Used illicit drugs in the past 12 months
  Never 1224 (89.0) 72 (5.9) 1152 (94.1) 0.74
  Yes, amphetamine-type stimulant 
(Yama, Crystal Ice, Ecstasy)
139 (10.1) 8 (5.8) 131 (94.2)
  Other (marijuana, heroin) 12 (0.9) 1 (8.3) 11 (91.7)
Injected any illicit drugs in the past three months
  No 1355 (98.6) 78 (5.8) 1277 (94.2) 0.01
  Yes 20 (1.5) 3 (15.0) 17 (85.0)
Had sex during/after using illicit drugs in the past three months
  No 1286 (93.5) 76 (5.9) 1210 (94.1) 1.00
  Yes 89 (6.5) 5 (5.6) 84 (94.4)
*χ2 or Fisher’s exact test was used as appropriate.
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that poorly educated transgender women are reached 
with education, information, communication and skills 
related to HIV prevention and other health-related 
services.
Fifth, transgender women with self-reported STI symp-
toms (having ulcerations or sores in the genital area in 
the past 12 months) had a greater HIV prevalence. This is 
in line with existing evidence showing that STIs promote 
HIV transmission via a variety of biological mechanisms.40 
Transgender women with high rates of STIs, particularly 
ulcerative genital diseases, are at high risk of HIV acqui-
sition.2 3
Finally, transgender women who reported never using 
online services developed for transgender women or 
MSM had an increased risk of HIV infection. Low use 
of online services by key populations in Cambodia is 
iterated in other studies.41 Non-users of online services, 
which tend to provide HIV information, education and 
communication, might have riskier sexual behaviours. 
Our data suggest that transgender women who did not 
use online services had higher numbers of overall male 
sexual partners (10.2 vs 6.3, p=0.002) and male commer-
cial sexual partners (0.8 vs 0.6, p=0.001) in the past 
three months. Also, they had a higher rate of inconsis-
tent condom use with male commercial sexual partners 
in the past three months (48.5% vs 34.4%, p=0.004). 
Unfortunately, in this study, we did not collect the details 
about the type of the online services, which could refer 
to dating, health and social services, or another type of 
online service. Studies in other settings confirm that 
transgender women with multiple sexual partners are 
exposed to a riskier level of HIV infection.6 15 This finding 
suggests that access to community-based services tailored 
to transgender population can reduce their vulnerability 
to HIV as demonstrated in other settings.42 Sustaining 
and increasing the coverage of internet and peer-led 
community-based services for this population is partic-
ularly important, given that they are often unable to 
access health services due to stigmatisation and discrim-
ination,16 41 even in healthcare settings.18 As in other 
settings globally,9 only half of those who were infected 
with HIV were aware of their status, demonstrating the 
need to intensify HIV testing, including self-testing at the 
community level, which transgender women in Cambodia 
are willing to use.43 Our study also found that once diag-
nosed the coverage of antiretroviral therapy was high in 
this population.
lIMItAtIOns OF the stuDy
Our study covered only the capital city and 12 prov-
inces, which contain the highest numbers of transgender 
Table 5 Factors associated with HIV infection in multivariate logistic regression model
Variables in the final model Adjusted OR (95% CI) p Value
Community type
  Rural Reference
  Urban 2.7 (1.1 to 6.5) 0.03
Formal education attained
  Primary (0–6 years) 1.7 (1.1 to 2.9) 0.04
  High school or higher (≥7) Reference
Age (years)
  <25 Reference
  25–34 2.1 (1.2 to 3.6) 0.01
  ≥35 2.6 (1.3 to 5.4) 0.01
Frequency of express and/or dressing as a woman
  Not all the time Reference
  All the time 2.1 (1.2 to 3.8) 0.01
Ever self-injected hormone
  No Reference
  Yes 4.4 (1.1 to 17.3) 0.03
Ulcerations or sores in the genital area in the past 12 months
  No Reference
  Yes 3.0 (1.2 to 7.8) 0.02
Used online services developed for men who have sex with men/transgender in the past six months (eg, Facebook, website)
  No 1.9 (1.2 to 3.2) 0.01
  Yes Reference
*Variables in the table were the ones that remained statistically significant after several steps of model fitting.
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women. Since cities and provinces with fewer trans-
gender women were left out, these results may not be 
generalised to all transgender women nationally. Second, 
the initial participant seeds were identified and recruited 
by outreach workers of community-based organisations, 
which could introduce bias towards transgender women 
under their programmes, leading to a recruitment 
bias. This problem could be exacerbated by outreach 
workers interviewing some participants who had received 
services from their NGO, which could have induced 
the participants’ responses. Third, this study employed 
a self-reporting questionnaire on sensitive health and 
sexual behaviours, which may have been limited by social 
desirability bias. Fourth, although minimal, the mone-
tary incentive given to the participants to recruit seeds 
may have affected their genuine motivation to partake 
in the study, which could influence their responses. 
Fifth, we used the backward selection of variables in the 
multivariable analysis. By using this method, we possibly 
dropped one or more variables that could be significant 
if we kept them until the final model. Finally, as this study 
was cross-sectional, it reports associations at a given time 
and may not be construed to be reporting causal rela-
tionships.
COnClusIOns
This study demonstrates that HIV prevalence among 
transgender women in Cambodia remains persistently 
high. With the prevalence rate at 5.9%, higher prevalence 
was observed among transgender women who resided 
in urban areas, of older age, with low education levels, 
with previous genital sores, with a history of self-injected 
hormone and those who had never used online services 
developed for transgender women or MSM. Therefore, to 
eliminate new HIV infections among transgender women, 
tailored interventions need to focus on these subpopula-
tions and attendant risk factors.
Author affiliations
1FHI 360, Phnom Penh, Cambodia
2KHANA Center for Population Health Research, Phnom Penh, Cambodia
3Population Services Khmer (PSK), Phnom Penh, Cambodia
4National Center for HIV/AIDS, Dermatology and STD (NCHADS), Phnom Penh, 
Cambodia
5Asia Pacific Regional Office, FHI 360, Phnom Penh, Cambodia
6Division of Health Research, Lancaster University, Lancaster, UK
7Center for Global Health Research, Touro University California, Vallejo, CA, United 
States
Acknowledgements This study was conducted in collaboration between the 
consortium partners of the HIV/AIDS Flagship Project including KHANA, FHI360, PSI/
PSK and the 13 Municipal and Provincial Health Departments under the leadership 
of National Center for HIV/AIDS, Dermatology and STD (NCHADS). The authors thank 
all implementing partners, data collection teams and participants in the study who 
fully supported during the study design and data collection. 
Contributors SC, ST, PM, CL, PC and SY designed the study, developed the 
research protocol and tools. SC, CN and SY analysed the data, interpreted the 
results and wrote the manuscript. PC, SC, CL, KP, ST and PM were responsible 
for training and data collection. JM, JD and GB supported findings analyses and 
manuscript writing. All authors read and approved the final manuscript.
Funding This study was conducted as part of the HIV/AIDS Flagship Project funded 
by President's Emergency Plan For AIDS Relief (PEPFAR) through the United States 
Agency for International Development (USAID).
Disclaimer Content of this paper is the responsibility of the authors and does not 
reflect the view of USAID or our respective institutions.
Competing interests None declared.
ethics approval National Ethics Committee for Health Research (NECHR) of the 
Ministry of Health, Cambodia (no. 420 NECHR) and FHI 360’s Protection of Human 
Subjects Committee (PHSC no. 713897).
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement Data used for this study cannot be made available in 
the manuscript, the supplemental files, or a public repository due to the ethical 
restriction stated in the agreement with the ethical committees. However, they can 
be accessed upon request from the principal investigator (SY) at  siyan@ doctor. com.
Open Access This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited and the use is non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2017. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
reFerenCes
 1. Baral SD, Poteat T, Strömdahl S, et al. Worldwide burden of HIV in 
transgender women: a systematic review and meta-analysis. Lancet 
Infect Dis 2013;13:214–22.
 2. Silva-Santisteban A, Raymond HF, Salazar X, et al. Understanding 
the HIV/AIDS epidemic in transgender women of Lima, Peru: results 
from a sero-epidemiologic study using respondent driven sampling. 
AIDS Behav 2012;16:872–81.
 3. Guadamuz TE, Wimonsate W, Varangrat A, et al. HIV prevalence, 
risk behavior, hormone use and surgical history among transgender 
persons in Thailand. AIDS Behav 2011;15:650–8.
 4. Brennan J, Kuhns LM, Johnson AK, et al. Adolescent Medicine Trials 
Network for HIV/AIDS Interventions. Syndemic theory and HIV-
related risk among young transgender women: the role of multiple, 
co-occurring health problems and social marginalization. Am J Public 
Health 2012;102:1751–7.
 5. Nemoto T, Operario D, Keatley J, et al. HIV risk behaviors among 
male-to-female transgender persons of color in San Francisco. Am J 
Public Health 2004;94:1193–9.
 6. Clements-Nolle K, Marx R, Guzman R, et al. HIV prevalence, risk 
behaviors, health care use, and mental health status of transgender 
persons: implications for public health intervention. Am J Public 
Health 2001;91:915–21.
 7. Gay and Lesbian Medical Association. Healthy people 2010 
Companion Document for Lesbian, gay, bisexual, and transgender 
(LGBT) Health. San Francisco, CA, United States: Gay and Lesbian 
Medical Association, 2001.
 8. Poteat T, Reisner SL, Radix A. HIV epidemics among transgender 
women. Curr Opin HIV AIDS 2014;9:168–73.
 9. United Nations Programme on HIV/AIDS (UNAIDS). Fast Track: 
Ending the AIDS Epidemic By 2030. Geneva, Switzerland: UNAIDS, 
2014.
 10. Wiessing LG, van Roosmalen MS, Koedijk P, et al. Silicones, 
hormones and HIV in transgender street prostitutes. AIDS 
1999;13:2315–6.
 11. Global Forum on MSM and HIV. MSM and HIV/AIDS Risk in Asia: 
What Is Fueling the Epidemic Among MSM and How Can It Be 
Stopped? Oakland, CA, United States: Global Forum on MSM and 
HIV, 2006.
 12. De Santis JP. HIV infection risk factors among male-to-female 
transgender persons: a review of the literature. J Assoc Nurses AIDS 
Care 2009;20:362–72.
 13. Operario D, Nemoto T, Iwamoto M, et al. Unprotected sexual 
behavior and HIV risk in the context of primary partnerships for 
transgender women. AIDS Behav 2011;15:674–82.
 14. Bockting WO, Robinson BE, Forberg J, et al. Evaluation of a sexual 
health approach to reducing HIV/STD risk in the transgender 
community. AIDS Care 2005;17:289–303.
group.bmj.com on August 30, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
12 Chhim S, et al. BMJ Open 2017;7:e015390. doi:10.1136/bmjopen-2016-015390
Open Access 
 15. Bockting WO, Robinson BE, Rosser BR. Transgender HIV prevention: 
a qualitative needs assessment. AIDS Care 1998;10:505–25.
 16. Chakrapani V, Newman PA, Shunmugam M, et al. Syndemics of 
depression, alcohol use, and victimisation, and their association 
with HIV-related sexual risk among men who have sex with men and 
transgender women in India. Glob Public Health 2017;12:250–65.
 17. Nemoto T, Iwamoto M, Perngparn U, et al. HIV-related risk behaviors 
among kathoey (male-to-female transgender) sex workers in 
Bangkok, Thailand. AIDS Care 2012;24:210–9.
 18. Scheim AI, Santos GM, Arreola S, et al. Inequities in access to HIV 
prevention services for transgender men: results of a global survey 
of men who have sex with men. J Int AIDS Soc 2016;19(3 Suppl 
2):20779.
 19. Schneiders ML, Weissman A. Determining barriers to creating an 
enabling environment in Cambodia: results from a baseline study 
with key populations and police. J Int AIDS Soc 2016;19(4 Suppl 
3):20878.
 20. Brennan J, Kuhns LM, Johnson AK, et al. Syndemic theory and HIV-
related risk among young transgender women: the role of multiple, 
co-occurring health problems and social marginalization. Am J Public 
Health 2012;102:1751–7.
 21. Raiford JL, Hall GJ, Taylor RD, et al. The role of structural barriers in 
Risky Sexual Behavior, victimization and readiness to Change HIV/
STI-Related risk Behavior among Transgender Women. AIDS Behav 
2016;20:2212–21.
 22. Weissman A, Ngak S, Srean C, et al. HIV prevalence and risks 
associated with HIV infection among transgender individuals in 
Cambodia. PLoS One 2016;11:e0152906.
 23. Chhorvann C, Vonthanak S. Estimations and projections of HIV/AIDS 
in Cambodia 2010-2015. Phnom Penh, Cambodia: National Center 
for HIV/AIDS, Dermatology and STDs 2011.
 24. Liu K, Chhea C. The BROS Khmer: behavioral risks on-site 
serosurvey among at-risk urban men in Cambodia. . Phnom Penh, 
Cambodia: FHI, 2010.
 25. National Center for HIV/AIDS, Dermatology and STD (NCHADS) 
Standard Operation Procedure (SoP) for Boosted Continuum of 
Prevention to Care and treatment for most at risk Population in 
Cambodia. Phnom Penh, Cambodia: NCHADS, 2013.
 26. Mun P, Chhim S, Chhoun P, et alNational Popualtion size estimation, 
HIV related risk Behaoviors, and HIV prevlence among men who sex 
with men in Cambodia in 2014Phnom Penh, Cambodia NCHADS/
KHANA 2016.
 27. Size estimation of Transgender Population in Cambodia.Phnom Penh, 
Cambodia: FHI, 2012.
 28. National Center for HIV/AIDS, detamatology and STD (NCHADS). 
Standard operating procedures for HIV testing and counseling (HTC). 
Phnom Penh, Cambodia: NCHADS, 2012.
 29.  Behavioral Surveilance surveys (BSS). Guideline for Repeated 
behavioral Surveys in Population at Risk of HIV. Washington DC, 
United States: FHI, 2000.
 30. Mun P, Sopheab H, Tuot S, et al. National HIV sentinel survey among 
women attending antenatal care in Cambodia 2014. Phnom Penh, 
Cambodia NCHADS 2016.
 31. National Center for HIV/AIDS, Dermatology and STDs (NCHADS). 
Cambodia Sub-National HIV estimates and Projection. Phnom Penh, 
Cambodia: NCHADS, 2016.
 32. Yi S, Chhim S, Chhoun P, et al. Men who have sex with men in 
Cambodia: population size, HIV risky behaviors, and HIV prevalence. 
Am J Epidemiol Infect Dis 2016;4:91–9.
 33. Nuttbrock L, Hwahng S, Bockting W, et al. Lifetime risk 
factors for HIV/sexually transmitted infections among male-
to-female transgender persons. J Acquir Immune Defic Syndr 
2009;52:417–21.
 34. Melendez RM, Pinto R. 'It's really a hard life': love, gender and HIV 
risk among male-to-female transgender persons. Cult Health Sex 
2007;9:233–45.
 35. Sevelius JM. Gender Affirmation: A Framework for Conceptualizing 
Risk Behavior among Transgender Women of Color. Sex Roles 
2013;68:675–89.
 36. Sausa LA, Keatley J, Operario D. Perceived risks and benefits of sex 
work among transgender women of color in San Francisco. Arch Sex 
Behav 2007;36:768–77.
 37. Yi S, Ngin C, Tuot S, et al. HIV prevalence, risky behaviors, 
and discrimination experiences among transgender women in 
Cambodia:Descriptive findings from a 651 national integrated 
biological and behavioral survey: BMC Int Health Hum Rights. In 
Press, 2016.
 38. Sanchez NF, Sanchez JP, Danoff A, et al. Health care utilization, 
barriers to care, and hormone usage among male-to-female 
transgender persons in New York City. Am J Public Health 
2009;99:713–9.
 39. Simon PA, Reback CJ, Bemis CC, et al. HIV prevalence and 
incidence among male-to-female transsexuals receiving HIV 
prevention services in Los Angeles County. AIDS 2000;14:2953–5.
 40. Fleming DT, Wasserheit JN. From epidemiological synergy to 
public health policy and practice: the contribution of other sexually 
transmitted diseases to sexual transmission of HIV infection. Sex 
Transm Infect 1999;75:3–17.
 41. Innovate HIV, Project E. University Research Co. LLC (URC-HIEP). 
evaluation of the HIV program for Transgender Women in Cambodia. 
Phnom Penh, Cambodia: URC-HIEP, 2016.
 42. Shaikh S, Mburu G, Arumugam V, et al. Empowering communities 
and strengthening systems to improve transgender health: outcomes 
from the Pehchan programme in India. J Int AIDS Soc 2016;19(3 
Suppl 2):20809.
 43. Pal K, Ngin C, Tuot S, et al. Acceptability Study on HIV Self-Testing 
among Transgender Women, Men who Have Sex with Men, and 
Female Entertainment Workers in Cambodia: A Qualitative Analysis. 
PLoS One 2016;11:e0166129.
group.bmj.com on August 30, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
Biological and Behavioral Survey
Cambodia: results from a national Integrated
HIV infection among transgender women in 
HIV prevalence and factors associated with
Mburu and Siyan Yi
Phalkun Mun, Khondyla Pal, John Macom, Jean-Philippe Dousset, Gitau 
Srean Chhim, Chanrith Ngin, Pheak Chhoun, Sovannary Tuot, Cheaty Ly,
doi: 10.1136/bmjopen-2016-015390
2017 7: BMJ Open 
 http://bmjopen.bmj.com/content/7/8/e015390




This article cites 29 articles, 1 of which you can access for free at: 
Open Access
 http://creativecommons.org/licenses/by-nc/4.0/non-commercial. See: 
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms, 
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections






To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on August 30, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
